Embodiments relate to genomic technologies using adaptive spline analysis that predict responses of cancer cells. For example, responses of cancer cells to specific medications and/or treatments may be predicted based on adaptive linear spline analyses.
STATEMENT REGARDING FEDERALLY SPONSORED R&D
 This invention was made with government support under Grant Number 5U54CA112970-04 awarded by the National Cancer Institute, and under Contract No. DE-AC02-05CH11231 awarded by the Department of Energy. The government has certain rights in the invention.
PARTIES OF JOINT RESEARCH AGREEMENT
 This invention was partially funded through Work for Others Agreement LB06-002417 between The Regents of the University of California through Ernest Orlando Lawrence Berkeley National Laboratory under its U.S. Department of Energy Contract No. DE-AC02-05CH11231 and GlaxoSmithKline, Inc.